|Articles|May 1, 2004
- Pharmaceutical Executive-05-01-2004
May 2004 Table of Contents
May 2004 Table of Contents
Advertisement
Articles in this issue
about 22 years ago
The Risk Management Mandateabout 22 years ago
Partners in Learningabout 22 years ago
Early WarningsAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond JAK Inhibitors: Biologics Signal a New Era in Alopecia Areata
2
Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Johnson & Johnson Acquires Firefly Bio
3
Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI
4
Roche Enters $2.3 Billion Global Collaboration with Nurix Therapeutics to Co-Develop and Co-Commercialize Bexobrutideg
5